Myqorzo

Active Ingredient(s): Aficamten
FDA Approved: * December 19, 2025
Pharm Company: * CYTOKINETICS
Category: Heart (Cardiac)
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Myqorzo 5 mg Oral Tablet, Film Coated
NDC: 82112-105
Labeler:
Cytokinetics Inc.
Myqorzo 10 mg Oral Tablet, Film Coated
NDC: 82112-110
Labeler:
Cytokinetics Inc.
Myqorzo 15 mg Oral Tablet, Film Coated
NDC: 82112-115
Labeler:
Cytokinetics Inc.
Myqorzo 20 mg Oral Tablet, Film Coated
NDC: 82112-120
Labeler:
Cytokinetics Inc.